Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Life Sciences|May 14, 2021
SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting β-catenin and epithelial to mesenchymal transition in lung cancerSurya Kant Tripathi, Bijesh Kumar BiswalPharmacological Research|April 14, 2020
Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agentSurya Kant Tripathi, Bijesh Kumar BiswalArchives of Toxicology|September 13, 2024
The phytochemical plumbagin: mechanism behind its "pleiotropic" nature and potential as an anticancer treatmentShikshya Swarupa Panda, Bijesh Kumar BiswalJournal of Biochemistry|August 21, 2009
Differential usage of the transport systems for folic acid and methotrexate in normal human T-lymphocytes and leukemic cellsBijesh Kumar Biswal, Rama Shanker VermaJournal of Cellular Biochemistry|November 1, 2024
Shikonin Stimulates Mitochondria-Mediated Apoptosis by Enhancing Intracellular Reactive Oxygen Species Production and DNA Damage in Oral Cancer CellsStuti Biswal, Munmun Panda, Bijesh Kumar BiswalDrug Discovery Today|May 31, 2022
SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistanceSurya Kant Tripathi, Rajeev Kumar Sahoo, Bijesh Kumar BiswalNaunyn-Schmiedeberg'S Archives of Pharmacology|January 27, 2024
Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer cellsSurya Kant Tripathi, Rajeev Kumar Sahoo, Bijesh Kumar BiswalJournal of Liposome Research|July 25, 2020
Electroformation of liposomes and phytosomes using copper electrodeHimadri Gourav Behuria, Bijesh Kumar Biswal, Santosh Kumar SahuArchives of Pharmacal Research|February 9, 2020
Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS inductionSurya Kant Tripathi, Kannan R R Rengasamy, Bijesh Kumar BiswalMedical Oncology (Northwood, London, England)|December 11, 2025
Investigating therapeutic potential of Evodiamine by identifying differentially expressed genes in cisplatin resistance non-small cell lung cancerSambit Kumar Patra, Sambit Kumar Pradhan, Zahid Alim Ansari, et al.Pageof 2